Indies Pharma Jamaica Limited (JMSE: INDIES)
Jamaica flag Jamaica · Delayed Price · Currency is JMD
3.150
+0.120 (3.96%)
At close: Nov 29, 2024

Indies Pharma Jamaica Company Description

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica.

It offers prescription and over the counter drugs in tablet, topical creams, ointment, suspension, injection, capsule, sachet and dispersible tablet, oral mixture, cream, solution, gel, shampoo, drop, chewable tablet, syrup, nasal spray, vaginal cream and pessary, tonic, and oral powder and solution dosage forms.

The company provides its products for use as cardiovascular agents, including anti-hypertensive, circulation and anti-thrombotic, anti-cholesterol, venous circulation and hemorrhoids, gastro-intestinal, antibiotic, anti-diabetes, and antiviral agents.

In addition, it provides dermatology agents, such as antibiotics topical, antifungal, dermatology and anti-acne, NSAIDS and antipyretic, respiratory/ENT and allergy, cough and cold, ophthalmology, vaginal preparation, appetite stimulant, hematinics and vitamins, neurological, anti-psychiatry, steroids, hormones and contraceptives, oncological, anesthesiology, biotechnology/biosimilars, and nephrology agents, as well as contrast media for radiology.

The company was incorporated in 2003 and is headquartered in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc.

Indies Pharma Jamaica Limited
Country Jamaica
Founded 2003
Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Employees 71
CEO Guna Muppuri

Contact Details

Address:
1A Pimento Way
Montego Bay
Jamaica
Phone 876 940 7984
Website indiespharma.com

Stock Details

Ticker Symbol INDIES
Exchange Jamaica Stock Exchange
Fiscal Year November - October
Reporting Currency JMD
SIC Code 5122

Key Executives

Name Position
Guna Muppuri Chief Executive Officer
Vishnu Muppuri Chief Operating Officer